SAN DIEGO, June 24, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (“Apricus Bio”) (Nasdaq:APRI) (http://www.apricusbio.com) Chairman, President and Chief Executive Officer, Dr. Bassam Damaj, will present at the BIO International Conference in Washington, D.C. Dr. Damaj will deliver his presentation on Tuesday, June 28, 2011 at 10:15 a.m. at the Walter E. Washington Convention Center in Washington, D.C. In addition to a corporate presentation, Dr. Damaj will discuss the room temperature version of Vitaros® for erectile dysfunction, which is expected to have a shelf life of two years; Dr. Damaj will also present the latest positive analysis done by the key opinion leader, Dr. A. Gupta, at Mediprobe Research, of the US Phase III trials of the Company’s anti-fungal drug candidate MycoVa™.
